Evidence map›Paper›PMID 25384353›Full record

ArticleExpert review of anti-infective therapy2015

Management of diarrhea in HIV-affected infants and children.

Patricia B Pavlinac, Kirkby D Tickell, Judd L Walson

Abstract readEditorial
In one paragraph

Article in Expert review of anti-infective therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Patricia B PavlinacUniversity of Washington, Global Health, 325 Ninth Avenue, Box 359931, Seattle, WA 98104, USA.
Kirkby D Tickell
Judd L Walson

Funding

VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
Prevalence and Correlates of NTS Bacteremia, Diarrhea and Carriage in KenyaU19AI090882 · NIAID · UNIVERSITY OF WASHINGTON · PI KEMNER, JOHN M · 2010 to 2014
$5.6M
NIAID NIH HHS T32 AI007140NIAID NIH HHS U19 AI090882PHS HHS U19-A2090882
6 · The paper itself

Abstract

Globally, diarrhea is the second leading cause of death in children less than 5 years of age. HIV-infected and HIV-exposed uninfected (HEU) children are at high risk of dying from diarrhea and may be more susceptible to the highest risk enteric pathogens. This increased risk associated with HIV infection and HIV exposure is likely multifactorial. Factors such as immunosuppression, proximity to individuals more likely to be shedding pathogens, and exposure to antimicrobial prophylaxis may alter the risk profile in these children. Current international guidelines do not differentiate management strategies on the basis of whether children are infected or affected by HIV, despite likely differences in etiologies and consequences. Reducing diarrhea mortality in high HIV prevalence settings will require strengthening of HIV testing and treatment programs; improvements in water, sanitation and hygiene interventions targeted at HIV-affected households; and reconsideration of the use of empiric antimicrobial treatment of pathogens known to infect HIV-infected and HEU children disproportionately.

Indexed as

AIDS-Related Opportunistic InfectionsAnti-Infective AgentsChild, PreschoolDiarrhea, InfantileHIV InfectionsHumansImmunocompromised HostInfantInfant, NewbornTrimethoprim, Sulfamethoxazole Drug CombinationWorld Health OrganizationAnti-Infective AgentsTrimethoprim, Sulfamethoxazole Drug CombinationchildrendiarrheaHIV exposureHIV infectionmanagement

Identifiers

PMID25384353
PMCPMC4609505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.